. Participants included athletes from 29 U.S. states and 26 countries. This report updates the ongoing investigation of this outbreak through December 2, which suggests that Leptospira were the cause of illness and that water from the Segama River was the primary source of infection. Participants in adventure sports and exotic tourism should be aware of potential exposure to unusual and emerging infectious agents.
the Dip-S-Ticks assay, but negative by IgM ELISA. Specimens from the seven participants who did not meet the case definition tested negative by both assays. Acute serum specimens were collected for culture innoculation in two athletes; one of these yielded a culture-grown isolate, and the other culture was negative at 6 weeks postinnoculation. Identification of the culture-confirmed isolate is pending. To identify other causes for febrile illnesses, testing for alternative organisms was conducted on a limited number of submitted samples positive for leptospirosis; four of four samples tested negative for dengue and for Orientia tsutsugamushi, both of which cause illness clinically similar to leptospirosis. Further testing of other samples for these pathogens is pending.
To identify potential exposure risks, information was gathered about participation in various portions of the race. Significant risk factors on univariate analysis included kayaking (risk ratio [RR]=3.0; 95% confidence interval [CI]=1.1-8.3); swimming in the Segama River (RR=2.3; 95% CI=1.4-3.8); spelunking (RR= 2.2; 95% CI=1.1-4.2); and swallowing water from the Segama River (RR=2.0; 95% CI=1.2-3.2). When subjected to stepwise logistic regression, only participating in the river swim was significantly associated with illness. Attributable risk for swimming in the river was 38%.
On September 13, on the basis of epidemiologic evidence and the initial screening Dip-S-Ticks assay results, CDC issued an advisory about the probable leptospirosis outbreak associated with the Eco-Challenge event (1 ) . In addition, CDC made recommendations about the treatment of leptospirosis. The Eco-Challenge organization also attempted to contact members of the race support staff and race volunteers to inform them about potential illness among these persons.
Editorial Note: Among ill Eco-Challenge participants, symptomatology and exposure history and the subsequent laboratory serologic testing suggest that leptospirosis was the cause of this outbreak. Leptospira species are endemic in Malaysian Borneo but were not recognized to be causing a large burden of disease at the time of Eco-Challenge. The epidemiology of leptospirosis and the epidemiologic data gathered from this investigation suggest a point source of the outbreak. Ill athletes who did not report swimming in the Segama River probably were exposed to contaminated water during other activities. However, some ill persons may have been infected with other pathogens, and further testing is ongoing. Recent increases in the number of persons participating in adventure sports and exotic tourism have led to infection with previously "unusual" organisms (3) (4) (5) (6) (7) . Participants in such events should be made aware of potential risks for exposure to unusual and emerging infectious agents, and their physicians should consider infection with these agents.
Leptospirosis is a zoonotic disease of worldwide distribution that causes an acute febrile illness; the incubation period is usually 5 to 14 days, but ranges from 2 to 30 days. The illness often is characterized by the abrupt onset of fever, chills, myalgias, and headache, and may include conjunctivitis, abdominal pain, vomiting, diarrhea, and skin rashes. An acute septicemic phase can be followed by a secondary phase of severe disease characterized by aseptic meningitis, jaundice, renal failure, and hemorrhage; the disease sometimes can progress rapidly to acute respiratory distress syndrome. Mild infections can be treated with oral doxycycline; more severe infections generally require intravenous penicillin (2 ) .
Initial screening for leptospirosis by CDC laboratories was performed using the Dip-S-Ticks assay, an enzyme-linked dot immunoassay for detecting IgM antibodies; recent evaluations carried out at CDC indicate that the Dip-S-Ticks assay appears to have significantly greater sensitivity early in infection than other available assays (CDC, unpublished data, 2000), with a sensitivity of approximately 27% at 3 days following onset of fever, increasing to 84% for specimens collected within 7-9 days, and reaching nearly 100% by 10-12 days. Accurate diagnosis of leptospirosis has been hampered by the difficulty of the serologic testing with the gold standard microscopic agglutination test. The high sensitivity and specificity of the newer rapid assays in early infection, their ease of use, and stability in field settings probably will result in earlier and more accurate diagnosis of leptospirosis.
Several studies have demonstrated the efficacy of pre-exposure chemoprophylaxis on clinical symptoms and mortality attributed to leptospirosis using oral doxycycline at 200 mg once a week (8, 9 ) . On the basis of the high attack rate and the high proportion of hospitalizations in otherwise healthy athletes, CDC recommended empiric treatment of all ill athletes with doxycycline and that asymptomatic athletes discuss postexposure prophylaxis with their health-care provider. Persons traveling to areas where leptospirosis is endemic or epidemic and who participate in high-risk exposure activities are at increased risk for leptospirosis and may benefit from pre-exposure chemoprophylaxis. CDC is collecting data to assess the benefits of pre-exposure doxycycline chemoprophylaxis.
Health-Related Quality of Life Among Persons With Epilepsy -Texas, 1998
Epilepsy is a central nervous system disorder characterized by unprovoked, recurrent seizures that may affect physical, mental, or behavioral functioning (1 ). In 1995, approximately 2.3 million persons residing in the United States had epilepsy. Approximately 181,000 new cases of epilepsy are diagnosed each year, with annual estimated costs of $12.5 billion in medical care and lost productivity (2, 3 ) . Because epilepsy has a substantial impact on health (e.g., physical and psychosocial difficulties, side effects of anticonvulsant therapy, lifestyle restrictions, and perceived stigmatization) (1,4-6 ), selfreported physical and mental health-related quality of life (HRQOL) measures are useful in gauging the impact of epilepsy on persons with the disorder. Persons with chronic health disorders are at risk for impaired HRQOL (7 ) . Few studies have examined the HRQOL of persons with epilepsy (5, 6 ) , and none has used a representative sample of adults residing in the United States. This report examines data from the 1998 Texas Behavioral Risk Factor Surveillance System (BRFSS) that included a question about epilepsy; findings indicate that persons with epilepsy reported substantially worse HRQOL than persons without epilepsy. Community-based interventions such as the Sepulveda Epilepsy Education Program that address medication self-management, Epilepsy -Continued *Thirteen persons without epilepsy did not answer, refused to answer, or were unsure about answering the question about general health status.
psychosocial self-management, and other education interventions can improve the quality of life for persons with epilepsy (8 ) .
BRFSS is an ongoing, state-based, random-digit-dialed telephone survey of the civilian, noninstitutionalized population aged ³18 years that tracks the prevalence of key health and safety-related behaviors and characteristics (9 ) . BRFSS data are weighted to reflect the age, sex, and racial/ethnic distribution of the state's estimated population during the survey year. The standard survey used in all states includes four self-rated questions: general health status, number of days during the 30 preceding the survey when physical health was not good, number of days during the preceding 30 when mental health was not good, and number of days during the preceding 30 when activity was limited as a result of poor physical or mental health. Unhealthy days are the total number of days when physical and mental health were not good, with the total not to exceed 30 days. In 1998, Texas added an optional quality of life module to its healthy days' measures that asked respondents about the nature of their activity limitations and the number of days of pain, depression, anxiety, insufficient sleep or rest, and overall vitality during the preceding 30 days. One question was added about epilepsy.
Persons with epilepsy were defined as those who reported having been told by a doctor that they had epilepsy or a seizure disorder. The responses to HRQOL questions from 3355 persons residing in Texas were analyzed using sample weights and SUDAAN statistical software to account for the complex survey design.
In Texas in 1998, 52 (1.8%) (95% confidence interval=1.4-2.1) of 3355 respondents reported having epilepsy. These respondents did not differ in age and sex from those without epilepsy. Those with epilepsy reported substantially worse HRQOL than those without epilepsy; 18 (45.9%) respondents with epilepsy reported fair or poor health compared with 570 (18.5%) of 3290 respondents without epilepsy*. Compared with those without epilepsy, respondents with epilepsy reported 4.4 more physically unhealthy days, 5.2 more mentally unhealthy days, 6.4 more overall unhealthy days, 4.0 more recent activity limitation days, 6.8 more days of pain, 5.6 more days of depression, 5.2 more days of anxiety, 3.5 more days of insufficient sleep or rest, and 3.3 fewer days of vitality in the 30 days preceding the survey (Table 1) Editorial Note: On the basis of HRQOL responses to the 1998 Texas BRFSS questionnaire, respondents with epilepsy had substantially worse HRQOL than respondents without epilepsy based on valid HRQOL measures (10 ) . These findings are comparable with the number of unhealthy days among BRFSS respondents from eight other states with arthritis, heart problems, diabetes, and cancer (7 ). Additional study is needed to determine whether the high number of reported days with pain in persons with epilepsy is associated with seizure severity, injuries from seizures, unintended effects of anticonvulsant medications, or other factors. The high number of days with depression and anxiety suggests that this population has high levels of anxiety and low levels of life fulfillment (1, 5, 6 ) .
The findings in this report are subject to at least four limitations. First, BRFSS excludes persons without telephones, in institutions (e.g., nursing homes and the military), and persons aged <18 years. Second, BRFSS may underrepresent the severely impaired because time and functional capacity are required to participate in BRFSS. Third, it is unclear whether lower levels of HRQOL in persons with epilepsy in this study are a result of the disorder or factors unrelated to epilepsy. Finally, because the sample size of respondents with epilepsy was small, comparisons by sex and racial/ethnic subgroup were limited. To improve the HRQOL of persons with epilepsy, the International Commission on Outcome Measurement in Epilepsy has recommended further research into the HRQOL among persons with epilepsy (6 ). In addition, BRFSS and other surveillance systems can provide data on the health status, behaviors, and HRQOL of persons with epilepsy. State and local health departments can collaborate with health-care providers to develop and promote comprehensive and continual care among minorities, children, the elderly, and other underserved populations. Schools, worksites, and places of worship can educate the public to destigmatize epilepsy, and interventions such as the Sepulveda Epilepsy Education Program can improve medication self-management and psychosocial selfmanagement of epilepsy (8 ) . - - 
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